HealthStream, Inc. (NASDAQ:HSTM) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• HealthStream, Inc. (NASDAQ:HSTM) has received a consensus rating of “Moderate Buy” from six research firms, with an average target price of $31.00.
• The company reported $0.18 earnings per share for the last quarter, surpassing analyst expectations, and has set its FY 2025 guidance for earnings.
• HealthStream announced a quarterly dividend of $0.031 per share, with an annualized yield of 0.5% and a payout ratio of 17.91%.

HealthStream, Inc. (NASDAQ:HSTM - Get Free Report) has earned an average rating of "Moderate Buy" from the six research firms that are presently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $31.00.

A number of equities research analysts recently commented on the company. Canaccord Genuity Group decreased their price objective on HealthStream from $29.00 to $28.00 and set a "hold" rating for the company in a research note on Thursday, August 7th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of HealthStream in a research note on Saturday, September 27th.

HealthStream Price Performance

Shares of HSTM stock traded down $0.16 on Friday, reaching $27.36. 141,826 shares of the stock were exchanged, compared to its average volume of 198,879. The stock has a market cap of $810.95 million, a PE ratio of 40.84, a P/E/G ratio of 3.45 and a beta of 0.47. HealthStream has a one year low of $25.36 and a one year high of $34.24. The stock has a 50 day moving average price of $27.63 and a 200 day moving average price of $28.74.

HealthStream (NASDAQ:HSTM - Get Free Report) last released its earnings results on Monday, August 4th. The technology company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.16 by $0.02. The company had revenue of $74.40 million during the quarter, compared to the consensus estimate of $74.39 million. HealthStream had a return on equity of 5.70% and a net margin of 6.89%. HealthStream has set its FY 2025 guidance at EPS. On average, research analysts expect that HealthStream will post 0.63 earnings per share for the current fiscal year.

HealthStream Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 18th were paid a dividend of $0.031 per share. The ex-dividend date of this dividend was Monday, August 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.5%. HealthStream's payout ratio is 17.91%.

Insider Activity at HealthStream

In other HealthStream news, EVP Kevin P. O'hara sold 2,000 shares of the business's stock in a transaction dated Wednesday, August 27th. The stock was sold at an average price of $27.97, for a total value of $55,940.00. Following the completion of the transaction, the executive vice president directly owned 17,137 shares of the company's stock, valued at approximately $479,321.89. The trade was a 10.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 20.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Copeland Capital Management LLC raised its holdings in HealthStream by 101.3% during the first quarter. Copeland Capital Management LLC now owns 763,690 shares of the technology company's stock worth $24,576,000 after acquiring an additional 384,384 shares in the last quarter. Robeco Institutional Asset Management B.V. raised its holdings in HealthStream by 162.1% during the second quarter. Robeco Institutional Asset Management B.V. now owns 380,604 shares of the technology company's stock worth $10,531,000 after acquiring an additional 235,382 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in HealthStream by 302.0% during the second quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company's stock worth $6,860,000 after acquiring an additional 186,231 shares in the last quarter. Qube Research & Technologies Ltd raised its holdings in HealthStream by 77.3% during the second quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company's stock worth $6,972,000 after acquiring an additional 109,883 shares in the last quarter. Finally, Bridgeway Capital Management LLC bought a new stake in HealthStream in the first quarter valued at approximately $3,228,000. 69.58% of the stock is owned by institutional investors and hedge funds.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.